semaglutide cost
Surprise Savings Slash Prescription Weight Loss Cost
Semaglutide and tirzepatide are the leading GLP-1 drugs for obesity, with clinical trials showing an average 15%-20% body-weight reduction. In 2023, Wegovy achieved a 15% loss, while Zepbound reached 22% in its pivotal study. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice.
